Frontlight ResearchEarly access
Type 1 diabetes trials in Italy
20 of 30 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Bologna, Florence, Genoa, Messina, Milan, Novara, Pescara, Rome, Siena, Turin, Verona
- Age
- 1 year to 25 years
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - Phase 3Taking peopleA Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Where
- Ancona, Bologna, Cagliari, Florence, Milan, Naples, Novara, Padova, Verona
- Age
- 1 year to 35 years
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00 - Phase 3Active, not recruitingA Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Where
- Ancona, Florence, Messina, Milan, Naples, Novara, Padova, Verona
- Age
- 1 year to 35 years
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00 - No phaseTaking peopleDifferentiating Heart Disease Between Adult-onset Autoimmune and Type 2 Diabetes
- Where
- Rome
- Age
- 30 years and over
- People
- 200
- Run by
- University of Roma La Sapienza
See details and how to joinNCT07911007 - Phase 3Not yet taking people in ItalyA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Bologna, Milan, Palermo, Pisa, Rome, Rozzano, Sesto San Giovanni, Turin
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - Phase 4Not yet taking people in ItalyAnti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A
- Where
- Milan
- Age
- Up to 17 years
- People
- 2,365 worldwide
- Run by
- Klinikum rechts der Isar der TU Muenchen AöR
See details and how to join2023-507348-35-00 - Phase 2Taking peopleSAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Where
- Milan, Novara, Verona
- Age
- 5 years to 40 years
- People
- 159 worldwide
- Run by
- SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00 - Phase 3Active, not recruitingA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Ancona, Bologna, Brescia, Catanzaro, Genoa, Messina, Milan, Perugia, Pisa
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - Phase 3Taking peopleA trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
- Where
- Bologna, Catania, Chieti, Florence, Latina, Milan, Pisa, Ravenna, Rome, San Donato Milanese
- Age
- 18 years and over
- People
- 1,010 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524688-19-00 - Phase 3Taking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Milan
- Age
- 18 years to 65 years
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - Phase 3Not yet taking people in ItalyAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Catanzaro, Chiavari, Chieti, Lucca, Milan, Naples, Ravenna, Roma
- Age
- 45 years and over
- People
- 1,778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - No phaseNot yet taking people in ItalyEvaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes
- Where
- Bologna, Milan, Naples, Roma
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- Medtronic MiniMed, Inc.
See details and how to joinNCT07401901 - No phaseTaking peopleVey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded Hybrid Closed Loop System
- Where
- Bari
- Age
- 18 years to 99 years
- People
- 14
- Run by
- Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
See details and how to joinNCT07185555 - No phaseTaking peopleGlycemic Response to Carbob-Enriched Pasta in Healthy and With Type 1 Diabetes People
- Where
- Naples
- Age
- 18 years to 50 years
- People
- 10
- Run by
- Federico II University
See details and how to joinNCT06994403 - Phase 1/2Taking peopleA First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes
- Where
- Padova
- Age
- 18 years to 40 years
- People
- 15
- Run by
- Altheia Science
See details and how to joinNCT06938334 · EU 2025-521304-21-00 - No phaseTaking peopleAssociation Between Sarcopenia And Diabetic Neuropathy In Adults With Type 1 Diabetes, A Pilot Study
- Where
- Rome
- Age
- 50 years to 80 years
- People
- 150
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06902597 - No phaseTaking peopleAuto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease
- Where
- Florence
- Age
- 2 years to 13 years
- People
- 1,500
- Run by
- Meyer Children's Hospital IRCCS
See details and how to joinNCT06849622 - No phaseTaking peopleIntervention on New Onset-T1D Children
- Where
- Milan
- Age
- 7 years to 17 years
- People
- 60
- Run by
- IRCCS San Raffaele
See details and how to joinNCT05767450 - Phase 2/3Not yet taking people in ItalyEffects of Sitagliptin in Relatives of T1D Patients
- Where
- Milan
- Age
- 10 years to 45 years
- People
- 70
- Run by
- University of Milan
See details and how to joinNCT05219409 - Phase 4Taking peopleInsulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients
- Where
- Naples
- Age
- 18 years to 30 years
- People
- 150
- Run by
- University of Campania Luigi Vanvitelli
See details and how to joinNCT03463564